Doctor profile · Federal record
Dr. DANIEL BRELIAN, M.D.
Internal Medicine Physician (CMS: GASTROENTEROLOGY) · Internal Medicine Physician · LOS ANGELES, CA
- NPI 1700032497
- Accepts Medicare
- 18 yrs in practice
- Licensed in 2 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
711 W COLLEGE ST, SUITE 203
LOS ANGELES, CA 900121163
(213) 830-8960
fax (213) 972-0977 - Mailing address
-
PO BOX 11816
BELFAST, ME 049154009
Credentials & registration
- NPI registered
- August 2008 — 18 yrs on file
- Profile last updated
- March 24, 2016
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State licenses (2)
- California #A109924 · District of Columbia #146762
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1700032497. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,029
Distinct HCPCS
10
Medicare allowed
$406,427
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 2,491 | 99 | $83 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 909 | 92 | $125 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 215 | 143 | $139 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 99 | 83 | $182 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 80 | 78 | $177 | |
G0316 |
Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | 76 | 76 | $32 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 66 | 66 | $180 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 54 | 52 | $86 | |
91200 |
Measurement of liver stiffness | 25 | 25 | $35 | |
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | 13 | $251 |
In context: peer comparison
Among 262 peers in this city , average services per provider: 160. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$10,406
Transactions
123
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 24 | $6,311.26 | |
| IRONWOOD PHARMACEUTICALS, INC | 4 | $2,060.15 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 27 | $543.57 | |
| Madrigal Pharmaceuticals | 15 | $493.88 | |
| QOL Medical, LLC | 16 | $254.65 | |
| PFIZER INC. | 13 | $195.53 | |
| Janssen Biotech, Inc. | 6 | $154.53 | |
| Ardelyx, Inc. | 4 | $102.63 | |
| Celgene Corporation | 6 | $99.85 | |
| Boston Scientific Corporation | 2 | $50.15 | |
| Gilead Sciences, Inc. | 2 | $47.63 | |
| Merck Sharp & Dohme LLC | 2 | $45.22 | |
| GENZYME CORPORATION | 1 | $33.50 | |
| RedHill Biopharma Inc. | 1 | $13.73 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,845
Patients
1,573
Total drug cost
$1,532,735
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Famotidine | Generic | 875 | 360 | $25,725 |
| Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl) | Brand | 515 | 491 | $8,607 |
| Pantoprazole Sodium | Generic | 245 | 169 | $4,249 |
| Creon (Lipase/Protease/Amylase) | Brand | 237 | 80 | $626,386 |
| Linzess (Linaclotide) | Brand | 208 | 79 | $217,859 |
| Xifaxan (Rifaximin) | Brand | 162 | 46 | $582,018 |
| Dicyclomine Hcl | Generic | 107 | 43 | $2,656 |
| Lactulose | Generic | 82 | 27 | $4,179 |
| Sucralfate | Generic | 75 | 47 | $10,270 |
| Peg-3350 And Electrolytes (Peg3350/Sod Sulf,bicarb,cl/Kcl) | Brand | 71 | 68 | $1,275 |